1,3-diisopropyl-tetrahydropyrimidin-2(1H)-one | 38692-91-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 1,3-diisopropyl-tetrahydropyrimidin-2(1H)-one
• 英文别名: 1,3-Di(propan-2-yl)-1,3-diazinan-2-one
• CAS: 38692-91-0
• 化学式: C₁₀H₂₀N₂O
• 分子量: 184.282
• InChiKey: WKONSTMXWKCZHL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  23.6
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  丙烯脲 、 三聚丙烯 在 氯[2-(二叔丁基磷)二苯基]金 、 silver trifluoromethanesulfonate 作用下， 以 1,4-二氧六环 为溶剂， 100.0 ℃ 、827.39 kPa 条件下， 反应 67.0h， 以86%的产率得到1,3-diisopropyl-tetrahydropyrimidin-2(1H)-one
  参考文献：
  名称：

  Zhang, Zhibin; Lee, Seong Du; Widenhoefer, Ross A., Journal of the American Chemical Society, 2009, vol. 131, p. 5372 - 5373

  摘要：

  DOI：

文献信息

• [EN] ACC INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE L'ACC ET UTILISATIONS ASSOCIÉES
  申请人：GILEAD APOLLO LLC

  公开号：WO2017075056A1

  公开（公告）日：2017-05-04

  The present invention provides compounds I and II useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.

  本发明提供了化合物I和II，这些化合物可用作乙酰辅酶A羧化酶（ACC）的抑制剂，以及它们的组合物和使用方法。
• Glycopeptide Antibiotic Derivative
  申请人：Nishitani Yasuhiro

  公开号：US20090286717A1

  公开（公告）日：2009-11-19

  The present invention provides a novel glycopeptide antibiotic derivative. These derivatives are represented by the formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein R A is —X 1 —Ar 1 —X 2 —Y—X 3 —Ar 2 wherein X 1 , X 2 and X 3 are single bond; heteroatom-containing group selected from the group consisting of —N═, ═N—, —NR 1 — (R 1 is hydrogen or lower alkyl), —O—, —S—, —SO— and —SO 2 —, or a linkage thereof; or alkylene or alkenylene optionally substituted and optionally interrupted by one or more of said heteroatom-containing group; Y is —NR 2 CO—, —CONR 2 — (R 2 is hydrogen or lower alkyl), or a group of the formula (II) wherein R 3 is alkylene; Ar 1 and Ar 2 are a carbocycle or a heterocycle which is optionally substituted and may have an unsaturated bond; R B is —NHNR X R Y or —NR Z OR W wherein R X is hydrogen or lower alkyl; R Y is hydrogen, optionally substituted lower alkyl, C(═NH)NH 2 , CSNH 2 , COCONH 2 , CN, optionally substituted heterocyclic group, and optionally substituted carbamoyl; R Z is hydrogen or lower alkyl; R W is hydrogen, optionally substituted lower alkyl, optionally substituted lower alkenyl, optionally substituted heterocyclic group, optionally substituted heterocyclic carbonyl or optionally substituted carbamoyl; R C is hydrogen or optionally substituted alkyl, wherein said alkyl may be interrupted by a heteroatom-containing group selected from N═, ═N—, —NR 1 — (R 1 is hydrogen or lower alkyl), —O—, —S—, —SO— and —SO 2 —; and R is optionally substituted alkyl.

  本发明提供了一种新型的糖肽抗生素衍生物。这些衍生物由以下式（I）或其药学上可接受的盐或溶剂表示，其中RA为—X1—Ar1—X2—Y—X3—Ar2，其中X1、X2和X3为单键；从—N═、═N—、—NR1—（R1为氢或较低的烷基）、—O—、—S—、—SO—和—SO2—中选择的含有杂原子的基团，或者它们的连接；或者由一个或多个上述含有杂原子的基团选择性取代和选择性中断的烷基或烯基；Y为—NR2CO—、—CONR2—（R2为氢或较低的烷基），或者具有以下式（II）的基团，其中R3为烷基；Ar1和Ar2为可能取代且可能具有不饱和键的碳环或杂环；RB为—NHNRXRY或—NRZORW，其中RX为氢或较低的烷基；RY为氢、选择性取代的较低烷基、C(═NH)NH2、CSNH2、COCONH2、CN、选择性取代的杂环基团和选择性取代的氨基甲酰；RZ为氢或较低的烷基；RW为氢、选择性取代的较低烷基、选择性取代的较低烯基、选择性取代的杂环基团、选择性取代的杂环酰基或选择性取代的氨基甲酰；RC为氢或选择性取代的烷基，其中所述的烷基可以被从—N═、═N—、—NR1—（R1为氢或较低的烷基）、—O—、—S—、—SO—和—SO2—中选择的含有杂原子的基团中断；且R为选择性取代的烷基。
• Process for producing cyclic ureas
  申请人：MITSUI TOATSU CHEMICALS, Inc.

  公开号：EP0248220A2

  公开（公告）日：1987-12-09

  A process for producing a cyclic urea by reacting a diamine directly with phosgene with a high yield and a cheap cost is provided, which process comprises reacting a diamine expressed by the formula wherein R represents hydrogen atom or a lower alkyl group and R' represents dimethylene group, trimethylene group, tetramethylene group or a lower alkyl group-substituted dimethylene group, trimethylene group or tetramethylene group except for three particular combination of R with R', with phosgene substantilly in the presence of water and a dehydrochlorinating agent to obtain a cyclic urea expressed by the formula wherein R and R' are as defined above.

  本发明提供了一种通过二胺直接与光气反应生产环状脲的工艺，其产率高且成本低，该工艺包括将式中 R 代表氢原子或低级烷基，R'代表二甲苯基团、三甲苯基团、四甲苯基团或低级烷基取代的二甲苯基团、三甲苯基团或四甲苯基团（R 与 R'的三种特定组合除外）的二胺与光气在水和脱氢氯化剂存在下进行反应，得到式中 R 和 R'如上定义的环状脲。
• ACC inhibitors and uses thereof
  申请人：Gilead Apollo, LLC

  公开号：US10179793B2

  公开（公告）日：2019-01-15

  The present invention provides compounds useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.

  本发明提供了可用作乙酰辅酶羧化酶（ACC）抑制剂的化合物、其组合物及其使用方法。
• Glycopeptide Antibiotic Monomer Derivatives
  申请人：Arimoto Hirokazu

  公开号：US20080097078A1

  公开（公告）日：2008-04-24

  Novel glycopeptide antibiotic derivatives. These derivatives are represented by the formula (aglycon part of glycopeptide antibiotic derivative)-(Sac-NH)—R A [wherein (aglycon part of glycopeptide antibiotic derivative) is the part formed by removing the sugar part from a known glycopeptide antibiotic derivative; (Sac-NH) part is an amino sugar part or a sugar chain part containing an amino sugar; and R A represents, e.g., the formula —X 1 —Ar 1 —X 2 —Y—X 3 —Ar 2 (wherein X 1 , X 2 , and X 3 each represents 1) a single bond or 2) a heteroatom or heteroatom-containing group selected from the group consisting of —N═, ═N—, —NR 1 —, —O—, etc.; Y represents —NR 2 CO— or —CONR 2 — (wherein R 2 represents hydrogen or lower alkyl), etc.)]. These derivatives have antibacterial activity against vancomycin-resistant bacteria.